Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Breast Neoplasms and CCR5[original query] |
---|
The delta32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population. Clinical biochemistry 2005 Mar 38 (3): 248-52. Degerli Naci, Yilmaz Emire, Bardakci Fev |
CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development. International journal of molecular medicine 2009 Mar 23 (3): 429-35. Aoki Mateus Nobrega, da Silva do Amaral Herrera Ana Cristina, Amarante Marla Karine, do Val Carneiro Juliana Laino, Fungaro Maria Helena Pelegrinelli, Watanabe Maria Angelica Eha |
p.R72P, PIN3 Ins16bp polymorphisms of TP53 and CCR5?32 in north Indian breast cancer patients. Asian Pacific journal of cancer prevention : APJCP 2012 13 (7): 3305-11. Guleria Kamlesh, Sharma Sarika, Manjari Mridu, Uppal Manjit Singh, Singh Neeti Rajan, Sambyal Vasud |
Association of chemotactic factor receptor 5 gene with breast cancer. Genetics and molecular research : GMR 2013 12 (4): 5289-300. Zhang Y, Meng F Y, Li W L, Zhou C X, Guan Z, Fan H |
Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women. International journal of molecular epidemiology and genetics 2013 4 (4): 218-27. Bodelon Clara, Malone Katheleen E, Johnson Lisa G, Malkki Mari, Petersdorf Effie W, McKnight Barbara, Madeleine Margaret |
Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis. Journal of receptor and signal transduction research 2014 Sep 1-7. Lee Young Ho, Song Gwan G |
Evaluation of CCL5 -403 G>A and CCR5 ?32 gene polymorphisms in patients with breast cancer. Cancer biomarkers : section A of Disease markers 2014 14 (5): 343-51. Eskandari-Nasab Ebrahim, Hashemi Mohammad, Ebrahimi Mahboubeh, Amininia Shadi, Bahari Gholamreza, Mashhadi Mohammad-Ali, Taheri Mohs |
Improved metastasis-free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations. International journal of cancer. Journal international du cancer 2015 Jan 136 (1): 91-7. Span P N, Pollakis G, Paxton W A, Sweep F C G J, Foekens J A, Martens J W M, Sieuwerts A M, van Laarhoven H W |
CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer. Clinical and experimental medicine 2015 Feb . Banin-Hirata Bruna Karina, Losi-Guembarovski Roberta, Oda Julie Massayo Maeda, de Oliveira Carlos Eduardo Coral, Campos Clodoaldo Zago, Mazzuco Tânia Longo, Borelli Sueli Donizete, Ceribelli Jesus Roberto, Watanabe Maria Angelica Eha |
The association between CCR5 ?32 polymorphism and susceptibility to breast cancer. Oncotarget 2017 Oct 8 (47): 82796-82802. Li Junlong, Peng Yuan, Liu Hui, Wu Qia |
Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5?32) among breast cancer patients of Pakistan. Molecular biology reports 2019 Mar . Fatima Faria, Saleem Saima, Hameed Abdul, Haider Ghulam, Ali Zaidi Syed Aqib, Kanwal Madiha, Zehra Sitwat, Azhar Ab |
CCL5 protein level: influence on breast cancer staging and lymph nodes commitment. Molecular biology reports 2019 11 46 (6): 6165-6170. Derossi Daniela Rudgeri, Amarante Marla Karine, Guembarovski Roberta Losi, de Oliveira Carlos Eduardo Coral, Suzuki Karen Mayumi, Watanabe Maria Angelica Ehara, de Syllos Cólus Ilce Ma |
Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population. Iranian journal of public health 2021 Mar 50 (3): 583-591. Tajbakhsh Amir, Farjami Zahra, Nesaei-Bajestani Abolfazl, Afzaljavan Fahimeh, Rivandi Mahdi, Moezzi Atefeh, Abedini Soheila, Asghari Mahla, Kooshyar Mohammad Mahdi, Homaei Shandiz Fatemeh, Pasdar Alire |
CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer. Aging 2021 10 13 (20): 23810-23830. Wang Xin, Han Yong, Peng Jiamin, He J |
Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5?32 mutation associated with the occurrence of breast cancer in Burkina Faso. Open life sciences 2024 4 19 (1): 20220847. Lassina Traoré, Mousso Savadogo, Abdou Azaque Zouré, Touwendpoulimdé Isabelle Kiendrebeogo, Fabienne Marie B T B Soudre, Soayebo Dabre, Aida Djé Djénéba Traore, Marc Donald Wilfried Adico, Tilate Lare, Teega-Wendé Clarisse Ouedraogo, Rogomenoma Alice Ouedraogo, Abdoul Karim Ouattara, Edwige T Yelemkoure, Alexis Yobi Sawadogo, Nayi Zongo, Hierrhum Aboubacar Bambara, Christelle W Nadembega, Florencia W Djigma, Jacques Simpo |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: